Evidence map›Paper›PMID 38041805›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Multimorbidity, cognitive phenotypes, and Alzheimer's disease plasma biomarkers in older adults: A population-based study.

Yifei Ren, Yuanjing Li, Na Tian, Rui Liu, Yi Dong, Tingting Hou, Cuicui Liu, Xiaolei Han, Xiaodong Han, Lidan Wang and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 4 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 4 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 5 countries.

Yifei RenDepartment of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, P. R. China.
Yuanjing LiAging Research Center and Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Stockholm University, Solna, Sweden.
Na TianDepartment of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, P. R. China.
Rui LiuDepartment of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, P. R. China.
Yi DongDepartment of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, P. R. China.
Tingting HouDepartment of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, P. R. China.
Cuicui LiuDepartment of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, P. R. China.
Xiaolei HanDepartment of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, P. R. China.
Xiaodong HanDepartment of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, P. R. China.
Lidan WangDepartment of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, P. R. China.
Davide Liborio VetranoAging Research Center and Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Stockholm University, Solna, Sweden.
Tiia NganduDepartment of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
Alessandra MarengoniAging Research Center and Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Stockholm University, Solna, Sweden.
Miia KivipeltoDivision of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden.
Yongxiang WangDepartment of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, P. R. China.
Lin CongDepartment of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, P. R. China.
Yifeng DuDepartment of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, P. R. China.ORCID 0000-0002-4672-6654
Chengxuan QiuDepartment of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, P. R. China.
Shandong University · CNStockholm University · SEKarolinska Institutet · SEKarolinska University Hospital · SE

Funding

Academic Promotion Program of Shandong First Medical University 2019QL020Integrated Traditional Chinese and Western Medicine Program in Shandong Province YXH2019ZXY008National Key R&D Program of China 2017YFC1310100National Natural Science Foundation of China 81772448National Natural Science Foundation of China 81861138008National Natural Science Foundation of China 82001120National Natural Science Foundation of China 82171175Provincial Natural Science Foundation of Shandong ZR2020QH098Provincial Natural Science Foundation of Shandong ZR2021MH005Provincial Natural Science Foundation of Shandong ZR2021QH240Shandong Provincial Key Research and Development Program 2021LCZX03STI2030-Major Projects 2021ZD0201801STI2030-Major Projects 2021ZD0201808STI2030-Major Projects 2022ZD0211600Swedish Foundation for International Cooperation in Research and Higher Education CH2019-8320Swedish Research Council 2017-05819Swedish Research Council 2020-01574
6 · The paper itself

Abstract

introductionTo examine the burden and clusters of multimorbidity in association with mild cognitive impairment (MCI), dementia, and Alzheimer's disease (AD)-related plasma biomarkers among older adults.

methodsThis population-based study included 5432 participants (age ≥60 years); of these, plasma amyloid beta (Aβ), total tau, and neurofilament light chain (NfL) were measured in a subsample (n = 1412). We used hierarchical clustering to generate five multimorbidity clusters from 23 chronic diseases. We diagnosed dementia and MCI following international criteria. Data were analyzed using logistic and linear regression models.

resultsThe number of chronic diseases was associated with dementia (multivariable-adjusted odds ratio = 1.22; 95% confidence interval [CI] = 1.11 to 1.33), AD (1.13; 1.01 to 1.26), vascular dementia (VaD) (1.44; 1.25 to 1.64), and non-amnestic MCI (1.25; 1.13 to 1.37). Metabolic cluster was associated with VaD and non-amnestic MCI, whereas degenerative ocular cluster was associated with AD (p < 0.05). The number of chronic diseases was associated with increased plasma Aβ and NfL (p < 0.05). DISCUSSION: Multimorbidity burden and clusters are differentially associated with subtypes of dementia and MCI and AD-related plasma biomarkers in older adults. HIGHLIGHTS: We used hierarchical clustering to generate five clusters of multimorbidity. The presence and load of multimorbidity were associated with dementia and mild cognitive impairment. Multimorbidity clusters were differentially associated with subtypes of dementia and Alzheimer's disease plasma biomarkers.

Indexed as

Alzheimer DiseaseCognitive DysfunctionDementia, VascularAgedAmyloid beta-PeptidesBiomarkersChronic DiseaseCognitionDisease ProgressionHumansMiddle AgedMultimorbidityPhenotypetau ProteinsAmyloid beta-PeptidesBiomarkerstau Proteinsdementiamild cognitive impairmentmultimorbidityplasma biomarkerspopulation-based studyrural

Identifiers

PMID38041805
PMCPMC10984420
OpenAlexW4389263733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.